Michelle Mathy is a principal at Capitol Counsel and brings an extensive background in healthcare provider and biopharmaceutical knowledge to the firm having cultivated more than a decade of experience in government relations at health care organizations and companies. Mathy’s expertise in health policy and politics is highlighted by her prior positions as Head of Federal Affairs at Otsuka America Pharmaceuticals Inc., and as Director of Congressional and Political Affairs at the American Academy of Dermatology Association (AADA).

At the AADA, Michelle was responsible for successfully influencing legislative and regulatory proposals affecting dermatology, including Medicare parts B, C, and D and led the Academy’s political affairs. Prior to joining Otsuka in 2021, Michelle was the Director of Government Affairs and Policy at Biogen, Inc., where she was a member of the Biosimilars Business Unit Leadership Team and led Biogen’s gene therapy policy work.

Michelle attended Southern Illinois University Carbondale, where she received a B.A. in Political Science and a B.S. in Communications. She began her career in health policy at the American Hospital Association. Additionally, Mathy has successfully run a $4 million PAC for the American Society of Anesthesiologists.